Process biology: Integrated genomics and bioinformatics tools for improved target assessment

John F. Reidhaar-Olson, Michael Braxenthaler, Juergen Hammer

Research output: Contribution to journalReview article

7 Scopus citations

Abstract

The availability of the human genome sequence has greatly increased the number of potential drug targets in recent years. As a result, the way targets are assessed has become crucial to the success of the drug discovery process. Unfortunately, the traditional methods relied on by the pharmaceutical industry to identify and validate targets are too slow and labor-intensive to be useful in the current environment. One solution to this dilemma is to adopt a new paradigm, which we call Process Biology. Process Biology integrates genomics and bioinformatics tools into automated, optimized modules that can be applied readily to a wide range of biological questions. By using organizational principles not usually applied to biological experiments, Process Biology can significantly impact target assessment and assist in decision-making throughout the drug discovery process.

Original languageEnglish (US)
Pages (from-to)189-195
Number of pages7
JournalDrug Discovery Today: TARGETS
Volume1
Issue number6
Publication statusPublished - Dec 1 2002

    Fingerprint

ASJC Scopus subject areas

  • Drug Discovery

Cite this

Reidhaar-Olson, J. F., Braxenthaler, M., & Hammer, J. (2002). Process biology: Integrated genomics and bioinformatics tools for improved target assessment. Drug Discovery Today: TARGETS, 1(6), 189-195.